Bonesupport Holding AB (publ) (BONEX.ST)
SEK 382.8
(2.03%)
SEK 382.8
(2.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -149.86 Million SEK | 18.48% |
| 2022 | -183.83 Million SEK | 0.65% |
| 2021 | -185.04 Million SEK | 46.09% |
| 2020 | -343.25 Million SEK | -320.25% |
| 2019 | -81.68 Million SEK | 68.76% |
| 2018 | -261.46 Million SEK | 39.86% |
| 2017 | -434.74 Million SEK | -1267.17% |
| 2016 | -31.79 Million SEK | -430.51% |
| 2015 | -5.99 Million SEK | -112.38% |
| 2014 | 48.41 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -146.71 Million SEK | -39.31% |
| 2024 Q2 | -99.18 Million SEK | 41.85% |
| 2024 Q1 | -170.57 Million SEK | -13.81% |
| 2023 Q1 | -174.01 Million SEK | 5.34% |
| 2023 FY | -149.86 Million SEK | 18.48% |
| 2023 Q4 | -149.86 Million SEK | 0.77% |
| 2023 Q3 | -151.02 Million SEK | -12.24% |
| 2023 Q2 | -134.56 Million SEK | 22.67% |
| 2022 Q2 | -151.97 Million SEK | 12.54% |
| 2022 Q1 | -173.76 Million SEK | 6.1% |
| 2022 FY | -183.83 Million SEK | 0.65% |
| 2022 Q4 | -183.83 Million SEK | 5.31% |
| 2022 Q3 | -194.14 Million SEK | -27.74% |
| 2021 Q3 | -214.46 Million SEK | 28.59% |
| 2021 FY | -185.04 Million SEK | 46.09% |
| 2021 Q1 | -328.94 Million SEK | 4.17% |
| 2021 Q2 | -300.34 Million SEK | 8.7% |
| 2021 Q4 | -185.04 Million SEK | 13.72% |
| 2020 Q2 | -383.26 Million SEK | -539.0% |
| 2020 Q3 | -367.34 Million SEK | 4.15% |
| 2020 FY | -343.25 Million SEK | -320.25% |
| 2020 Q1 | -59.97 Million SEK | 26.57% |
| 2020 Q4 | -343.25 Million SEK | 6.56% |
| 2019 FY | -81.68 Million SEK | 68.76% |
| 2019 Q1 | -206 Million SEK | 21.21% |
| 2019 Q2 | -161.21 Million SEK | 21.74% |
| 2019 Q4 | -81.68 Million SEK | 31.13% |
| 2019 Q3 | -118.6 Million SEK | 26.43% |
| 2018 Q2 | -368.35 Million SEK | 7.26% |
| 2018 FY | -261.46 Million SEK | 39.86% |
| 2018 Q4 | -261.46 Million SEK | 16.51% |
| 2018 Q3 | -313.16 Million SEK | 14.98% |
| 2018 Q1 | -397.17 Million SEK | 8.64% |
| 2017 Q3 | -476.28 Million SEK | -3.65% |
| 2017 Q4 | -434.74 Million SEK | 8.72% |
| 2017 FY | -434.74 Million SEK | -1267.17% |
| 2017 Q1 | 301 Thousand SEK | 100.95% |
| 2017 Q2 | -459.49 Million SEK | -152756.48% |
| 2016 Q1 | 68.88 Million SEK | 0.0% |
| 2016 Q4 | -31.79 Million SEK | 0.0% |
| 2016 FY | -31.79 Million SEK | -430.51% |
| 2015 FY | -5.99 Million SEK | -112.38% |
| 2014 FY | 48.41 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 102.987% |
| Biotage AB (publ) | -444 Million SEK | 66.246% |
| Doxa AB (publ) | -102.2 Million SEK | -46.641% |
| Elekta AB (publ) | 4.46 Billion SEK | 103.353% |
| iZafe Group AB (publ) | -2.65 Million SEK | -5536.217% |
| Ortivus AB (publ) | 4.19 Million SEK | 3675.072% |
| Ortivus AB (publ) | 4.19 Million SEK | 3675.072% |
| Q-linea AB (publ) | -61.33 Million SEK | -144.362% |
| S2Medical AB (publ) | -1.51 Million SEK | -9778.987% |
| Synsam AB (publ) | 2.67 Billion SEK | 105.607% |